Furthermore, inhibition of SRF or MKL1 by knockdown or treatment with the MKL inhibitor CCG-1423 attenuates the growth of SMO inhibitor resistant BCC cells ([58] and Table 2). The gene discussed is MRTFA; the disease is skin basal cell carcinoma.